News
Public · Published
Freedom Broker maintains Merck & Co at Hold, raises price target to $140 from $125
Freedom Broker kept its Hold rating on Merck & Co and raised its price target to $140 from $125, a 12.0% increase. The new target implies a 5.6% downside from Merck's November 2 close of $148.36.
Published:
Updated:
What happened
Freedom Broker kept its Hold rating on Merck & Co and raised its price target to $140 from $125, a 12.0% increase. The new target implies a 5.6% downside from Merck's November 2 close of $148.36.
Confirmed
Global impact / market context
A Hold rating with a target below the current share price suggests the analyst sees limited near-term upside after Merck's recent run. The higher target still signals more value than before, so investors get a mixed message rather than a clear sell signal.
Analyst inference
Other recent analyst targets on Merck range from $140 to $180, and ratings include Neutral, Overweight, Sector Perform, and Buy. Freedom Broker's $140 sits at the low end of that range, showing it is more cautious than several peers covering the same stock.
Analyst inference
What to watch
- Freedom Broker's $140 target compares with a November 2 close of $148.36, so watch whether Merck's shares move toward or away from that level. Confirmed
- Watch whether other analysts change their Merck ratings or price targets, since the recent range of $140 to $180 shows differing views on the stock. Proposed
- Watch Merck's future profit and revenue reports, because analyst targets and ratings often shift when company results differ from what analysts expected. Analyst inference
Evidence
- Original source link unavailable